Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Neovascular Age-Related Macular Degeneration (nAMD)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Research Network Arizona, Scottsdale, Arizona, United States

    Contact: Principal Investigator (Mark Barakat, MD)
  • Barnet Dulaney Perkins Eye Center, Sun City, Arizona, United States

    Contact: Principal Investigator (Suhail Alam, MD)
  • Retina Associates, Tucson, Arizona, United States

    Contact: Principal Investigator (Cameron Javid, MD)
  • Retinal Diagnostic Center, Campbell, California, United States

    Contact: Principal Investigator (Amr Dessouki, MD)
  • Retina Consultants of Orange County, Fullerton, California, United States

    Contact: Principal Investigator (Ashkan Pirouz, MD)
  • Northern California Retina Vitreous Associates, Mountain View, California, United States

    Contact: Principal Investigator (Mark Wieland, MD)
  • Retinal Consultants Medical Group Inc., Sacramento, California, United States

    Contact: Principal Investigator (Joel Pearlman, MD, PhD)
  • Retinal Consultants Medical Group, Sacramento, California, United States

    Contact: Principal Investigator (Margaret Chang, MD)
  • West Coast Retina Medical Group, San Francisco, California, United States

    Contact: Principal Investigator (Michael Jumper, MD)
  • Bay Area Retina Associates, Walnut Creek, California, United States

    Contact: Principal Investigator (Subhransu Ray, MD, PhD)
  • Retina Consultants of Southern Colorado P.C., Colorado Springs, Colorado, United States

    Contact: Principal Investigator (Standford Taylor, MD)
  • Southwest Retina Consultants, Durango, Colorado, United States

    Contact: Principal Investigator (Sara Haug, MD, PHD)
  • ClearVista Clinical Research, Hudson, Florida, United States

    Contact: Principal Investigator (Dana Deupree, MD, FASRS)
  • Florida Retina Institute, Orlando, Florida, United States

    Contact: Principal Investigator (Matthew Cunningham, MD, PhD)
  • Retina Specialty Institute, Pensacola, Florida, United States

    Contact: Principal Investigator (Sunil Gupta, MD)
  • Retina Vitreous Associates of Florida, St. Petersburg, Florida, United States

    Contact: Principal Investigator (David Eichenbaum, MD, FASRS)
  • East Florida Eye Institute, Stuart, Florida, United States

    Contact: Principal Investigator (Ronald Frenkel, MD)
  • Retina Vitreous Associates of Florida, Tampa, Florida, United States

    Contact: Principal Investigator (Ashley Crane, MD)
  • Thomas Eye Group, Sandy Springs, Georgia, United States

    Contact: Principal Investigator (Paul Kaufman, MD)
  • Retina Associates, Ltd., Elmhurst, Illinois, United States

    Contact: Principal Investigator (Aaron Weinberg, MD)
  • University Retina and Macula Associates, PC, Oak Forest, Illinois, United States

    Contact: Principal Investigator (Veeral Sheth, MD, MBA, FACS, FASRS)
  • Illinois Retina Associates, Oak Park, Illinois, United States

    Contact: Principal Investigator (Mathew MacCumber, MD, PhD)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Principal Investigator (Ramanath Bhandari, MD)
  • Retina Partners Midwest, PC, Carmel, Indiana, United States

    Contact: Principal Investigator (Raj Maturi, MD, FASRS)
  • The Retina Care Center, Baltimore, Maryland, United States

    Contact: Principal Investigator (Matthew Speicher, MD)
  • Cumberland Valley Retina Consultants, Hagerstown, Maryland, United States

    Contact: Principal Investigator (Allen Hu, MD)
  • Mid Atlantic Retina Specialist, Hagerstown, Maryland, United States

    Contact: Principal Investigator (Adam Gerstenblith, MD)
  • New England Retina Consultants, Springfield, Massachusetts, United States

    Contact: Principal Investigator (David Lally, MD)
  • Foundation for Vision Research, Grand Rapids, Michigan, United States

    Contact: Principal Investigator (Thomas Aaberg, MD)
  • Sierra Eye Associates, Reno, Nevada, United States

    Contact: Principal Investigator (Arshad Khanani, MD, MA, FASRS)
  • Envision Ocular, LLC, Bloomfield, New Jersey, United States

    Contact: Principal Investigator (Patrick Higgins, MD)
  • Retina Vitreous Surgeons of CNY PC, Liverpool, New York, United States

    Contact: Principal Investigator (Jamin Brown, MD)
  • New York Presbyterian Hospital - Columbia University Medical Center, New York, New York, United States

    Contact: Principal Investigator (Tongalp Tezel, MD)
  • Vitreoretinal Consultants of NY, Westbury, New York, United States

    Contact: Principal Investigator (James Lin, MD)
  • North Carolina Retina Associates, Cary, North Carolina, United States

    Contact: Principal Investigator (Rebecca Manning, MD)
  • North Carolina Retina Associates, Wake Forest, North Carolina, United States

    Contact: Principal Investigator (John Thordsen, MD)
  • Cincinnati Eye Institute, Cincinnati, Ohio, United States

    Contact: Principal Investigator (Robert Sisk, MD, FACS, FASRS)
  • Verum Research, LLC, Eugene, Oregon, United States

    Contact: Principal Investigator (Albert Edwards, MD, PhD, MBA)
  • EyeHealth Northwest, Portland, Oregon, United States

    Contact: Principal Investigator (Brian Chan-Kai, MD)
  • Erie Retina Research, Erie, Pennsylvania, United States

    Contact: Principal Investigator (David Almeida, MD, MBA, PhD, DABO, FRCSC, FAS)
  • Charleston Neuroscience Institute, LLC, Bluffton, South Carolina, United States

    Contact: Principal Investigator (Mona Camacci, MD, MS)
  • Carolina Eyecare, Mt. Pleasant, South Carolina, United States

    Contact: Principal Investigator (Jonathan Brugger, MD)
  • Palmetto Retina Center, West Columbia, South Carolina, United States

    Contact: Principal Investigator (Stephen Hypes, DO)
  • Black Hills Regional Eye Institute, Rapid City, South Dakota, United States

    Contact: Principal Investigator (Prema Abraham, MD)
  • Tennessee Retina, PC, Nashville, Tennessee, United States

    Contact: Principal Investigator (Carl Awh, MD, FASRS)
  • Southwest Retina Specialist - Panhandle Eye group, LLP, Amarillo, Texas, United States

    Contact: Principal Investigator (Jason Edward Ysasaga, MD)
  • Austin Clinical Research, Austin, Texas, United States

    Contact: Principal Investigator (Fuad Makkouk, MD)
  • Texas Retina Associate, Dallas, Texas, United States

    Contact: Principal Investigator (Ashkan Abbey, MD, FASRS, FAAO)
  • Tyler Retina Consultants, Tyler, Texas, United States

    Contact: Principal Investigator (Samuel Minaker, MD)
  • Strategic Clinical Research, Willow Park, Texas, United States

    Contact: Principal Investigator (Seong Young Lee, MD)
  • Rocky Mountain Retina Consultants, Salt Lake City, Utah, United States

    Contact: Principal Investigator (Mitchell Goff, MD)
  • Piedmont Eye Center, Lynchburg, Virginia, United States

    Contact: Principal Investigator (Golnaz Javey, MD)
  • Pacific Northwest Retina, Silverdale, Washington, United States

    Contact: Principal Investigator (Todd Schneiderman, MD, FASRS)
  • Eye Clinic of Wisconsin, Wausau, Wisconsin, United States

    Contact: Principal Investigator (Deepak Sambhara, MD, FASRS)
  • Grupo Láser Visión, Rosario, Santa Fe Province, Argentina

    Contact: Principal Investigator (Federico Furno Sola, MD)
  • Microcirugia Ocular Rosario, Rosario, Santa Fe Province, Argentina

    Contact: Principal Investigator (Matko Vidosevich, MD)
  • Centro Privado de Ojos, Buenos Aires, Argentina

    Contact: Principal Investigator (Rodrigo Santos, MD)
  • Charles Research Center, Buenos Aires, Argentina

    Contact: Principal Investigator (Patricio Gerardo Schlottmann, MD)
  • OFTALMOS, Buenos Aires, Argentina

    Contact: Principal Investigator (Arturo Alezzandrini, MD, PhD)
  • Centrovisión, Mendoza, Argentina

    Contact: Principal Investigator (Hernan Gras, MD)
  • Adelaide Eye and Retina Centre, Adelaide, Australia

    Contact: Principal Investigator (Jagjit Gilhotra, MBBS, MMed, FRANZCO)
  • Eye Clinic Albury Wodonga, Albury, Australia

    Contact: Principal Investigator (Alan Luckie, MB ChB, FRANZCO)
  • Strathfield Retina Clinic, Strathfield, Australia

    Contact: Principal Investigator (James Wong, MBBS, MMED, FRANZCO)
  • Sydney Retina Clinic and Day Surgery, Sydney, Australia

    Contact: Principal Investigator (Andrew Chang, MBBS, PhD FRANZCO, FRAC)
  • Zora Eye Hospital, Sofia, Bulgaria

    Contact: Principal Investigator (Iva Petkova, MD, PhD)
  • Internationale Innovative Ophthalmochirurgie GbR, Düsseldorf, Germany

    Contact: Principal Investigator (Hakan Kaymak, MD. PhD)
  • Augenzentrum Frankfurt, Frankfurt, Germany

    Contact: Principal Investigator (Frank Koch, MD, PhD)
  • Dietrich Bonhoeffer Klinikum, Neubrandenburg, Germany

    Contact: Principal Investigator (Christian Brinkmann, MD, FEBO)
  • Bajcsy-Zsilinszky Kórház, Budapest, Hungary

    Contact: Principal Investigator (Agnes Kerényi, MD, PhD)
  • Budapest Retina Associates, Budapest, Hungary

    Contact: Principal Investigator (András Seres, MD)
  • Semmelweis Egyetem - Szemészeti Klinika, Budapest, Hungary

    Contact: Principal Investigator (András Papp, MD, PhD)
  • DE KK Ophthalmology Clinic, Debrecen, Hungary

    Contact: Principal Investigator (Attila Vajas, MD)
  • Ganglion Medical Center, Pécs, Hungary

    Contact: Principal Investigator (Balazs Varsanyi, MD, PhD)
  • SzTE SZAKK Szemeszeti Klinika, Szeged, Hungary

    Contact: Principal Investigator (Edit Tóth-Molnár, MD, PhD)
  • AOU delle Marche, Ancona, Italy

    Contact: Principal Investigator (Marco Lupidi, MD, PhD)
  • Kozawa Eye Hospital and Diabetes Center, Mito, Ibaraki, Japan

    Contact: Principal Investigator (Genichiro Kishino, MD)
  • University of the Ryukyus Hospital, Ginowan, Okinawa, Japan

    Contact: Principal Investigator (Hideki Koizumi, MD, PhD)
  • Social Medical Corporation Foundation Chiyuukai Fukuoka Wajiro Hospital, Fukuoka, Japan

    Contact: Principal Investigator (Koji Murata, MD)
  • Hayashi Eye Hospital, Fukuoka, Japan

    Contact: Principal Investigator (Ken Hayashi, MD, PhD)
  • National Hospital Organization Tokyo Medical Center, Tokyo, Japan

    Contact: Principal Investigator (Kunihiko Akiyama, MD, PhD)
  • P.Stradins University Hospital, Riga, Latvia

    Contact: Principal Investigator (Guna Laganovska, MD, PhD)
  • Riga East University hospital, Riga, Latvia

    Contact: Principal Investigator (Kristīne Baumane, MD, PhD)
  • Ziemekurzemes Regionala Slimnica, Ventspils, Latvia

    Contact: Principal Investigator (Kaspars Ozols, MD)
  • Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania

    Contact: Principal Investigator (Vilma Balciuniene, MD, PhD)
  • Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

    Contact: Principal Investigator (Andrius Cimbalas, MD)
  • Aibili - Cec, Coimbra, Portugal

    Contact: Principal Investigator (Ines Marques, MD)
  • Singapore Eye Research Institute (SERI), Singapore, Singapore

    Contact: Principal Investigator (Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI)
  • Tan Tock Seng Hospital TTSH, Singapore, Singapore

    Contact: Principal Investigator (Nicola Gan, MBBS, MMed, FRCOphth)
  • Miranza Instituto Gomez-Ulla, Santiago de Compostela, Spain, Spain

    Contact: Principal Investigator (Maribel Fernández Rodríguez, MD, PhD)
  • Clinica Bonanova de Cirugía Ocular, Barcelona, Spain

    Contact: Principal Investigator (Ignasi Jürgens, MD, PhD)
  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Principal Investigator (Estanislao Gutierrez Sanchez, MD, PhD)
  • Bradford Royal Infirmary, Bradford, UK, United Kingdom

    Contact: Principal Investigator (Helen Devonport)
  • The Retina Clinic London, London, United Kingdom

    Contact: Principal Investigator (Paulo Eduardo Stanga, MD)
  • Sunderland Eye Infirmary, Sunderland, United Kingdom

    Contact: Principal Investigator (Ajay Kotagiri, MBBS, MRCOphth, FRCOphth)
מובילי המחקר
  • Julie Tsai, MD

    Study Director

    4D Molecular Therapeutics